NO942854L - Farmasöytiske blandinger med gode opplösningsegenskaper - Google Patents

Farmasöytiske blandinger med gode opplösningsegenskaper

Info

Publication number
NO942854L
NO942854L NO942854A NO942854A NO942854L NO 942854 L NO942854 L NO 942854L NO 942854 A NO942854 A NO 942854A NO 942854 A NO942854 A NO 942854A NO 942854 L NO942854 L NO 942854L
Authority
NO
Norway
Prior art keywords
ifetroban
optionally
dissolution properties
good dissolution
pharmaceutical mixtures
Prior art date
Application number
NO942854A
Other languages
English (en)
Norwegian (no)
Other versions
NO942854D0 (en:Method
Inventor
Faranak Nikfar
Abu T M Serajuddin
Robert L Jerzewski
Nemichand B Jain
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO942854D0 publication Critical patent/NO942854D0/no
Publication of NO942854L publication Critical patent/NO942854L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO942854A 1993-08-02 1994-08-01 Farmasöytiske blandinger med gode opplösningsegenskaper NO942854L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10080293A 1993-08-02 1993-08-02

Publications (2)

Publication Number Publication Date
NO942854D0 NO942854D0 (en:Method) 1994-08-01
NO942854L true NO942854L (no) 1995-02-03

Family

ID=22281616

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942854A NO942854L (no) 1993-08-02 1994-08-01 Farmasöytiske blandinger med gode opplösningsegenskaper

Country Status (15)

Country Link
EP (1) EP0638310A1 (en:Method)
JP (1) JPH07145052A (en:Method)
KR (1) KR950005309A (en:Method)
CN (1) CN1118254A (en:Method)
AU (1) AU6878294A (en:Method)
CA (1) CA2129099A1 (en:Method)
CZ (1) CZ181094A3 (en:Method)
FI (1) FI943569L (en:Method)
HU (1) HUT70951A (en:Method)
IL (1) IL110376A (en:Method)
NO (1) NO942854L (en:Method)
NZ (1) NZ264129A (en:Method)
PL (1) PL304508A1 (en:Method)
RU (1) RU94028273A (en:Method)
ZA (1) ZA945672B (en:Method)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
EP2263660B1 (en) 1998-05-18 2017-09-27 Takeda Pharmaceutical Company Limited Orally disintegrable tablets
MY151098A (en) 1998-07-28 2014-04-15 Takeda Pharmaceutical Rapidly disintegrable solid preparation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
JP4698000B2 (ja) * 2000-06-27 2011-06-08 旭化成ケミカルズ株式会社 水易溶性薬物含有錠剤
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
CN100438914C (zh) * 2003-10-15 2008-12-03 富士化学工业株式会社 用于口腔内快速崩解的片剂的组合物
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
HRP20130148T4 (hr) 2006-08-03 2016-10-07 Horizon Pharma Ag Liječenje reumatske bolesti glukokortikoidima s odgođenim otpuštanjem
MX2009010474A (es) * 2007-03-29 2009-10-19 Daiichi Sankyo Co Ltd Composicion farmaceutica.
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
GB201400034D0 (en) * 2014-01-02 2014-02-19 Astrazeneca Ab Pharmaceutical Compositions comprising AZD9291
US12161632B2 (en) 2014-05-16 2024-12-10 Cumberland Pharmaceuticals Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
AU2015258805B2 (en) 2014-05-16 2018-05-10 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
US20170000771A1 (en) 2015-06-30 2017-01-05 Cumberland Pharmaceuticals, Inc. Thromboxane Receptor Antagonists in AERD/Asthma
JP7653218B2 (ja) 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
JP7003062B2 (ja) 2016-05-11 2022-01-20 カンバーランド ファーマシューティカルズ，インコーポレーテッド トロンボキサンａ２受容体拮抗薬により筋ジストロフィーを治療する組成物及び方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
DD299186A5 (de) * 1990-10-01 1992-04-02 E.R. Squibb U. Sons,Inc.,Us Phenylen-7-oxabicycloheptyl-substituierte heterocycloamid-prostaglandinanaloga

Also Published As

Publication number Publication date
NO942854D0 (en:Method) 1994-08-01
CA2129099A1 (en) 1995-02-03
FI943569A7 (fi) 1995-02-03
FI943569L (fi) 1995-02-03
IL110376A (en) 1998-08-16
HUT70951A (en) 1995-11-28
HU9402254D0 (en) 1994-09-28
AU6878294A (en) 1995-02-09
CZ181094A3 (en) 1995-02-15
RU94028273A (ru) 1996-11-10
KR950005309A (ko) 1995-03-20
CN1118254A (zh) 1996-03-13
NZ264129A (en) 1996-05-28
EP0638310A1 (en) 1995-02-15
PL304508A1 (en) 1995-02-06
JPH07145052A (ja) 1995-06-06
ZA945672B (en) 1995-03-06
FI943569A0 (fi) 1994-07-29
IL110376A0 (en) 1994-10-21

Similar Documents

Publication Publication Date Title
NO942854L (no) Farmasöytiske blandinger med gode opplösningsegenskaper
DE69513254D1 (de) Gepirone enthaltende Zusammensetzungen
BR9913553A (pt) Formulação de ranolazina de liberação sustentada
ES2041810T3 (es) Un procedimiento para revestir una composicion de tabletas.
YU17092A (sh) Derivati 2,4-diaminohinazolina
FI932320A0 (fi) Kontrollerbart frisaettande kompositioner
TW335466B (en) Data processor and shade processor
YU4198A (sh) Karbapenem antibiotik, kompozicija i postupak za dobijanje
CA2076427A1 (en) Vinylidene chloride composition and film made therefrom
PE20000224A1 (es) Formulacion medicamentosa con liberacion controlada de sustancia activa
NO971860D0 (no) Matrikstablett som tillater en forlenget frigivelse av natriumsaltet av tianeptin etter oral administrasjon
HU9601718D0 (en) Impregnated sheet used as a basis for a decorative coating
NO954287D0 (no) Anvendelse av indolderivater som 5-HT1 agonister
PT946150E (pt) Preparado oral que contem numa matriz que pode intumescer-se num meio aquoso pelo menos uma substancia activa farmaceutica
AR022118A1 (es) Composiciones de hidroxipropil celulosa y polimero anionico y su uso como revestimientos de peliculas farmaceuticas
CA2526417A1 (en) Method of delaying the setting time of crosslinked lost circulation control pills
RU2002106727A (ru) Фармацевтическая композиция, содержащая ципрофлоксацин, и способ ее получения
JPH01175936A (ja) ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
KR940006586A (ko) 다층 알칼리 코팅에 의한 오메프라졸의 경구제제 및 그 제조방법
CA2163778A1 (en) Indole derivatives as steroid 5a-reductase inhibitors
RU94037742A (ru) Бумагоподобный материал для замедления твердения бетона
KR920019704A (ko) 요로용 통기성 복사체
RU2000118704A (ru) Состав для щелочной обработки текстильных материалов из гидратцеллюлозных волокон
DK0514267T3 (da) Hidtil ukendte amidderivater af 1-aminooctahydropyrido(2,1-c)(1,4)oxazin, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
TH48591A (th) สารผสมสำหรับผลิตก๊าซสำหรับใช้ในเครื่องเตรียมสร้างแรงตึง